Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:11.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Melanoma as a topic and linked related topics, including MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2026-03-04T13:46:22.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the lapse-in-funding notice and the government operating status update, and removed Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T04:41:03.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Added a site-wide notice about the lapse in government funding and open status, and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:31:16.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Show glossary has been added, and several metadata labels were updated (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Related topics and legacy labels (e.g., Melanoma, MedlinePlus Genetics, No FEAR Act data, Revision: v3.3.4) were removed.
    Difference
    0.4%
    Check dated 2026-01-28T03:54:04.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added Melanoma as a related topic and a MedlinePlus Genetics link as related topics on the study page.
    Difference
    0.2%
    Check dated 2026-01-21T04:45:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.